On Feb. 23, 2020, China's Center for Drug Evaluation (CDE) issued the Work Rules for the Disclosure of New Drugs' Technical Reports (Trial) 1. The document says, from Jun. 1, 2021, CDE will release the technical review reports and package inserts of all new drugs approved since Sept. 1, 2016. Innovative new drugs, improved new drugs, and imported original or improved drugs with overseas marketing authorization are the major types covered.
